Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Prothena Current Ratio 2011-2020 | PRTA

Prothena current ratio from 2011 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Prothena Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $0.34B $0.02B 18.40
2020-03-31 $0.36B $0.02B 21.05
2019-12-31 $0.38B $0.02B 21.36
2019-09-30 $0.41B $0.03B 12.88
2019-06-30 $0.42B $0.03B 14.95
2019-03-31 $0.42B $0.02B 27.85
2018-12-31 $0.43B $0.02B 28.90
2018-09-30 $0.46B $0.02B 19.34
2018-06-30 $0.49B $0.05B 10.71
2018-03-31 $0.54B $0.04B 15.11
2017-12-31 $0.43B $0.04B 11.41
2017-09-30 $0.47B $0.04B 11.95
2017-06-30 $0.51B $0.04B 12.92
2017-03-31 $0.51B $0.03B 15.27
2016-12-31 $0.39B $0.04B 9.53
2016-09-30 $0.42B $0.04B 11.26
2016-06-30 $0.45B $0.03B 13.47
2016-03-31 $0.48B $0.02B 20.75
2015-12-31 $0.38B $0.02B 16.99
2015-09-30 $0.39B $0.02B 21.21
2015-06-30 $0.41B $0.01B 30.19
2015-03-31 $0.28B $0.01B 29.80
2014-12-31 $0.30B $0.01B 24.85
2014-09-30 $0.31B $0.01B 30.97
2014-06-30 $0.31B $0.01B 27.14
2014-03-31 $0.20B $0.01B 22.27
2013-12-31 $0.18B $0.01B 24.07
2013-09-30 $0.10B $0.01B 13.34
2013-06-30 $0.11B $0.01B 12.51
2013-03-31 $0.12B $0.01B 23.75
2012-12-31 $0.13B $0.00B 72.16
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
2011-12-31 $0.00B $0.01B 0.01
2010-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.405B $0.001B
Prothena Corporation plc is a biotechnology company focused on the discovery and development of therapeutic monoclonal antibodies for disease-causing proteins. The Company is developing the following programs: NEOD001 for Amyloidosis, NEOD002 for Parkinson's disease, MCAM for Inflammatory disease and Metastatic Cancer and Tau for Alzheimer's disease. Prothena Corporation plc is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.804B 15.51
Bristol Myers Squibb (BMY) United States $134.607B 10.36
CSL (CSLLY) Australia $95.723B 0.00
Gilead Sciences (GILD) United States $78.044B 11.24
Vertex Pharmaceuticals (VRTX) United States $69.852B 38.98
Regeneron Pharmaceuticals (REGN) United States $61.076B 23.35
Illumina (ILMN) United States $43.784B 50.92
Biogen (BIIB) United States $43.264B 7.40
Seattle Genetics (SGEN) United States $32.181B 0.00
Moderna (MRNA) United States $27.412B 0.00
BeiGene (BGNE) Cayman Islands $25.529B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.080B 10.45
Genmab (GMAB) Denmark $23.560B 14.88
Genmab (GNMSF) Denmark $22.160B 5.10
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.865B 0.00
Immunomedics (IMMU) United States $19.730B 0.00
Incyte (INCY) United States $18.928B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.156B 37.80
Alnylam Pharmaceuticals (ALNY) United States $16.040B 0.00
BioNTech SE (BNTX) Germany $15.089B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
Exact Sciences (EXAS) United States $14.671B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.035B 101.83
QIAGEN (QGEN) Netherlands $11.825B 30.01
ARGENX SE-ADR (ARGX) Netherlands $11.685B 0.00
Sarepta Therapeutics (SRPT) United States $11.305B 0.00
Guardant Health (GH) United States $11.116B 0.00
Bio-Techne Corp (TECH) United States $9.321B 63.95
Galapagos (GLPG) Belgium $9.081B 32.90
Ascendis Pharma (ASND) Denmark $8.140B 0.00
Repligen (RGEN) United States $7.576B 120.25
Mirati Therapeutics (MRTX) United States $7.450B 0.00
Exelixis (EXEL) United States $7.366B 26.79
SWEDISH ORP BIO (BIOVF) Sweden $7.304B 18.17
MyoKardia (MYOK) United States $7.035B 0.00
Novavax (NVAX) United States $6.959B 0.00
Adaptive Biotechnologies (ADPT) United States $6.557B 0.00
Acceleron Pharma (XLRN) United States $6.477B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.336B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.237B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.901B 182.80
Emergent Biosolutions (EBS) United States $5.379B 21.31
Ultragenyx Pharmaceutical (RARE) United States $4.973B 0.00
Blueprint Medicines (BPMC) United States $4.864B 0.00
Zai Lab (ZLAB) China $4.609B 0.00
Vir Biotechnology (VIR) United States $4.563B 0.00
China Biologic Products (CBPO) China $4.349B 25.82
Arena Pharmaceuticals (ARNA) United States $4.248B 0.00
MorphoSys AG (MOR) Germany $4.163B 54.55
Legend Biotech (LEGN) United States $4.018B 0.00
NeoGenomics (NEO) United States $3.956B 1194.00
Bluebird Bio (BLUE) United States $3.777B 0.00
Denali Therapeutics (DNLI) United States $3.724B 0.00
Halozyme Therapeutics (HALO) United States $3.571B 0.00
Amicus Therapeutics (FOLD) United States $3.570B 0.00
Insmed (INSM) United States $3.411B 0.00
Global Blood Therapeutics (GBT) United States $3.325B 0.00
Principia Biopharma (PRNB) United States $3.323B 0.00
Fate Therapeutics (FATE) United States $3.283B 0.00
Twist Bioscience (TWST) United States $3.244B 0.00
Reata Pharmaceuticals (RETA) United States $3.153B 0.00
Inovio Pharmaceuticals (INO) United States $2.838B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.800B 0.00
Alkermes (ALKS) Ireland $2.662B 55.80
Sorrento Therapeutics (SRNE) United States $2.332B 0.00
PHARMA MAR SA (PHMMF) Spain $2.208B 0.00
I-Mab (IMAB) China $2.181B 0.00
Zymeworks (ZYME) Canada $2.061B 0.00
Mesoblast (MESO) Australia $2.058B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.035B 0.00
Seres Therapeutics (MCRB) United States $2.010B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Editas Medicine (EDIT) United States $1.831B 0.00
Intra-Cellular Therapies (ITCI) United States $1.809B 0.00
Eidos Therapeutics (EIDX) United States $1.738B 0.00
Revance Therapeutics (RVNC) United States $1.719B 0.00
UniQure (QURE) Netherlands $1.660B 0.00
Cytokineticsorporated (CYTK) United States $1.650B 0.00
Ligand Pharmaceuticals (LGND) United States $1.562B 52.81
Amarin (AMRN) Ireland $1.469B 0.00
Viela Bio (VIE) United States $1.468B 0.00
Zealand Pharma (ZEAL) Denmark $1.411B 0.00
Sangamo Therapeutics (SGMO) United States $1.406B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.390B 0.00
Beam Therapeutics (BEAM) United States $1.384B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.333B 0.00
Mersana Therapeutics (MRSN) United States $1.331B 0.00
Coherus BioSciences (CHRS) United States $1.316B 7.67
Intellia Therapeutics (NTLA) United States $1.250B 0.00
Epizyme (EPZM) United States $1.212B 0.00
Arcus Biosciences (RCUS) United States $1.148B 0.00
NGM Biopharmaceuticals (NGM) United States $1.129B 0.00
Compugen (CGEN) Israel $1.101B 0.00
REGENXBIO (RGNX) United States $1.040B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.030B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.024B 0.00
Athenex (ATNX) United States $1.013B 0.00
Alcobra (ARCT) United States $0.978B 0.00
Castle Biosciences (CSTL) United States $0.977B 0.00
Arvinas (ARVN) United States $0.958B 0.00
Heska (HSKA) United States $0.931B 0.00
Retrophin (RTRX) United States $0.931B 0.00
Myriad Genetics (MYGN) United States $0.929B 0.00
Genetron Holdings (GTH) China $0.897B 0.00
Alector (ALEC) United States $0.895B 0.00
Adverum Biotechnologies (ADVM) United States $0.872B 0.00
Vericel (VCEL) United States $0.827B 0.00
Morphic Holding (MORF) United States $0.820B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.788B 0.00
NantKwest (NK) United States $0.775B 0.00
Pliant Therapeutics (PLRX) United States $0.763B 0.00
Cellectis S.A (CLLS) France $0.758B 0.00
Agenus (AGEN) United States $0.737B 0.00
Protagonist Therapeutics (PTGX) United States $0.735B 0.00
VBI Vaccines (VBIV) United States $0.712B 0.00
MiMedx (MDXG) United States $0.706B 0.00
Codexis (CDXS) United States $0.698B 0.00
Frequency Therapeutics (FREQ) United States $0.690B 0.00
Pharming Group (PHGUF) Netherlands $0.682B 15.57
Kadmon Holdings (KDMN) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Intrexon (PGEN) United States $0.617B 0.00
Cara Therapeutics (CARA) United States $0.607B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.574B 0.00
Northwest Biotherapeutics (NWBO) United States $0.568B 0.00
Forte Biosciences (FBRX) United States $0.549B 0.00
Scholar Rock Holding (SRRK) United States $0.539B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.536B 0.00
Geron (GERN) United States $0.525B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.525B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.509B 4.46
Celldex Therapeutics (CLDX) United States $0.501B 0.00
Albireo Pharma (ALBO) United States $0.499B 0.00
Dynavax Technologies (DVAX) United States $0.491B 0.00
Anika Therapeutics (ANIK) United States $0.486B 21.25
Aquinox Pharmaceuticals (NLTX) United States $0.485B 0.00
IVERIC Bio (ISEE) United States $0.477B 0.00
Cue Biopharma (CUE) United States $0.477B 0.00
MeiraGTx Holdings (MGTX) United States $0.460B 0.00
Kala Pharmaceuticals (KALA) United States $0.436B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.430B 0.00
Starpharma Holdings (SPHRY) Australia $0.427B 0.00
Avid Bioservices (CDMO) United States $0.425B 0.00
MannKind (MNKD) United States $0.424B 0.00
Syros Pharmaceuticals (SYRS) United States $0.420B 0.00
Amryt Pharma (AMYT) United Kingdom $0.407B 0.00
UROGEN PHARMA (URGN) United States $0.404B 0.00
Athersys (ATHX) United States $0.403B 0.00
AnaptysBio (ANAB) United States $0.399B 0.00
Puma Biotechnology (PBYI) United States $0.389B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.381B 26.93
Kamada (KMDA) Israel $0.375B 17.92
PDL BioPharma (PDLI) United States $0.373B 0.00
Trevena (TRVN) United States $0.373B 0.00
Sutro Biopharma (STRO) United States $0.370B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
Fortress Biotech (FBIO) United States $0.356B 0.00
Merus (MRUS) Netherlands $0.350B 0.00
AC Immune SA (ACIU) Switzerland $0.343B 0.00
WAVE Life Sciences (WVE) Singapore $0.338B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.336B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 7.92
Precision BioSciences (DTIL) United States $0.321B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.315B 0.00
CytomX Therapeutics (CTMX) United States $0.314B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.308B 0.00
Innate Pharma S.A (IPHA) France $0.305B 0.00
OSMOTICA PHARM (OSMT) United States $0.270B 0.00
Cardiff Oncology (CRDF) United States $0.264B 0.00
Prometic Life Sciences (LMNL) Canada $0.261B 0.00
Selecta Biosciences (SELB) United States $0.259B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.259B 0.00
Affimed (AFMD) Germany $0.254B 0.00
Arbutus Biopharma (ABUS) United States $0.249B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Pluristem Therapeutics (PSTI) Israel $0.247B 0.00
Cyclerion Therapeutics (CYCN) United States $0.231B 0.00
NextCure (NXTC) United States $0.231B 0.00
TELA Bio (TELA) United States $0.222B 0.00
HOOKIPA Pharma (HOOK) United States $0.217B 0.00
Verastem (VSTM) United States $0.215B 0.00
XOMA (XOMA) United States $0.208B 0.00
Dyadic (DYAI) United States $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.202B 0.00
Liquidia Technologies (LQDA) United States $0.191B 0.00
Aduro Biotech (ADRO) United States $0.190B 0.00
ADMA Biologics Inc (ADMA) United States $0.188B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Cerecor (CERC) United States $0.182B 0.00
Kindred Biosciences (KIN) United States $0.176B 0.00
DBV Technologies S.A (DBVT) France $0.176B 0.00
Biofrontera AG (BFRA) Germany $0.175B 0.00
Eton Pharmaceuticals (ETON) United States $0.174B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.172B 0.00
Theratechnologies (THTX) Canada $0.171B 0.00
Checkpoint Therapeutics (CKPT) United States $0.169B 0.00
Five Prime Therapeutics (FPRX) United States $0.164B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.163B 7.60
GENFIT S.A (GNFT) France $0.159B 0.00
Abeona Therapeutics (ABEO) United States $0.158B 0.00
Exicure (XCUR) United States $0.153B 0.00
SESEN BIO, INC (SESN) United States $0.152B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
AquaBounty Technologies (AQB) United States $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Aptinyx (APTX) United States $0.147B 0.00
Aytu Bioscience (AYTU) United States $0.142B 0.00
Bellus Health (BLU) Canada $0.131B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
Celyad SA (CYAD) Belgium $0.128B 0.00
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
VTv Therapeutics (VTVT) United States $0.124B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.120B 0.00
Strongbridge Biopharma (SBBP) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.62
Antibe Therapeutics (ATBPF) Canada $0.105B 0.00
Gritstone Oncology (GRTS) United States $0.104B 0.00
Enzo Biochem (ENZ) United States $0.103B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.103B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Evogene (EVGN) Israel $0.100B 0.00
Catalyst Biosciences (CBIO) United States $0.098B 0.00
Unum Therapeutics (UMRX) United States $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.088B 0.00
Oncobiologics (OTLK) United States $0.086B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Ecology Coatings (ABVC) United States $0.077B 0.00
DiaMedica Therapeutics (DMAC) United States $0.077B 0.00
Edesa Biotech (EDSA) Canada $0.076B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Synlogic (SYBX) United States $0.071B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.071B 0.00
Adocia (ADOCY) France $0.067B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.059B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Curis (CRIS) United States $0.057B 0.00
TRACON Pharmaceuticals (TCON) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Novogen (KZIA) Australia $0.049B 0.00
Cocrystal Pharma (COCP) United States $0.048B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 67.50
AnPac Bio-Medical Science (ANPC) China $0.047B 0.00
Signal Genetics (MGEN) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Genetic Technologies (GENE) Australia $0.044B 0.00
Organovo Holdings (ONVO) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Pulmatrix (PULM) United States $0.037B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
Acorda Therapeutics (ACOR) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
OvaScience (MLND) United States $0.029B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
Celsion (CLSN) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
Cesca Therapeutics (THMO) United States $0.021B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00